TumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations

Similar documents
TumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations

Hereditary Gynecologic Cancer

patient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention

patient guide Hereditary Cancer genetic testing panels Because knowing your risk can mean early detection and prevention

OvaNext. patient guide. genetic testing for hereditary breast, ovarian, and uterine cancer

patient guide ProstateNext genetic testing for hereditary prostate cancer Because knowing your risk can mean early detection and prevention

BRCA1 and BRCA2. patient guide. genetic testing for hereditary breast and ovarian cancer (hboc)

Lynch Syndrome. patient guide. genetic testing for hereditary colorectal and uterine cancer

patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention

patient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

patient guide RenalNext genetic testing for hereditary kidney cancer Because knowing your risk can mean early detection and prevention

patient guide BrainTumorNext genetic testing for hereditary brain tumors Because knowing your risk can mean early detection and prevention

patient guide CancerNext-Expanded genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

patient guide Clinical Genomics genetic testing for undiagnosed diseases Taking the extra step to find answers

Hereditary Cardiovascular Conditions

Neurological Disorders

Commonly asked questions about genetic testing for hereditary cancer

Does Cancer Run in Your Family?

Why Test for Hereditary Cancer in Preventive Care?

patient education Fact Sheet

Screening for Genes for Hereditary Breast and Ovarian Cancer in Jewish Women

GeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information

Sequencing. Deletion/Duplication Analysis. How Does Genetic Testing for Cancer Work?

BRCAnowTM It s Your Decision

Sporadic Cancer - Cancer which occurs by chance. People with sporadic cancer typically do not have relatives with the same type of cancer.

GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center

Lynch Syndrome. A Patient s Guide to Genetic Testing for Lynch Syndrome

Because Knowledge is a Powerful Tool. Focused on Patients

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

Cancer - the Beginning: Biology, Pathology and Genetic Predisposition

WELCOME. Taking Care of Your Health. April 30, 8 am to noon

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

A Patient s Guide to. Hereditary Ovarian Cancer: Is Hereditary Cancer Testing Right for You?

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18

DO YOU HAVE A FAMILY HISTORY OF ONE OF THESE CANCERS? BREAST, OVARIAN, COLORECTAL, ENDOMETRIAL, PANCREAS, PROSTATE, STOMACH OR SKIN CANCERS?

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

Genetic testing for hereditary cancer. An overview for healthcare providers

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.

What s In Your Genes: How changes in the BRCA1/BRCA2 genes

Lori Carpenter, MS, LCGC Saint Francis Hospital

What Are Genes And Chromosomes?

BRCAplus. genetic testing for hereditary breast cancer

We know that treatments are now targeting genes, but does genetics play a bigger role in cancer outside of that?

Does Cancer Run in Your Family?

GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Shawnia Ryan, MS, LCGC Senior Genetic Counselor University of New Mexico Cancer Center

Welcome! Here s our agenda for today:

A Guide to Genetics and Health

GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer

CONSENT TO GENETIC TESTING THROUGH A RESEARCH STUDY

This information explains the advice about familial breast cancer (breast cancer in the family) that is set out in NICE guideline CG164.

Jill Stopfer, MS, CGC Abramson Cancer Center University of Pennsylvania

BRCA genes and inherited breast and ovarian cancer. Information for patients

I have ovarian cancer

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

FIRST NAME MI LAST NAME BIRTH DATE (MM/DD/YYYY) GENDER. Name of person previously tested and relationship:

Telephone Disclosure Visual Aid Toolkit: Panel Testing

Notes for slide 2 Welcome to today s training webinar. We appreciate everyone taking time today to hear our presentations. We are very excited to fina

GYNplus. genetic testing for hereditary ovarian and/or uterine cancer

Information for You and Your Family

The Genetics of Breast and Ovarian Cancer Prof. Piri L. Welcsh

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

BRCA1 & BRCA2 GeneHealth UK

Outline. Identifying your risk for hereditary breast or ovarian cancer. Genetics 101. What causes cancer? Genetics

First of all, why don t you each tell me a little bit about your background and what exactly genetic counselor is?

Genetic Counselor: Hi Lisa. Hi Steve. Thanks for coming in today. The BART results came back and they are positive.

BRCA 1/2. Breast cancer testing THINK ABOUT TOMORROW, TODAY

Long QT. Long QT Syndrome. A Guide for Patients

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

Genetic testing for hereditary cancer

I have ovarian cancer


HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond.

Genetic testing for breast cancer susceptibility

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing.

So how much of breast and ovarian cancer is hereditary? A). 5 to 10 percent. B). 20 to 30 percent. C). 50 percent. Or D). 65 to 70 percent.

Importance of Family History in Gynecologic Cancer Prevention. Objectives. Genetic Counselors. Angela Thompson, MS, CGC

Illumina Clinical Services Laboratory

Genetic Testing: who, what, why?

GeneHealth BRCA 1&2_ qxp_Layout 1 21/02/ :44 Page 3 BRCA1 & BRCA2 GeneHealth UK

POSITIVE DELETERIOUS MUTATION

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

The Next Generation of Hereditary Cancer Testing

No mutations were identified.

SHARSHERET. New Recommendations for Genetic Testing: How Do I Make Sense Of It All?

Understand your Genetic Risk for Cancer

Corporate Medical Policy Genetic Testing for Breast and Ovarian Cancer

Assessing the Status of BRCA Testing and the Challenges Faced by Cancer Care Teams in the Community

Assessing the Status of BRCA Testing and the Challenges Faced by Cancer Care Teams in the Community. Summary of Survey Findings April 2018

Applies to: All Aetna plans, except Traditional Choice plans. All Innovation Health plans, except indemnity plans

GENETIC TESTING FOR RETINAL DISEASES. A resource for the inherited retinal disease community

HBOC. Jessica M. Salamone, ScM, CGC

Are you at risk of Hereditary Cancer? Your Guide to the Answers

Media Contact: Ron Rogers Investor Contact: Scott Gleason (801) (801)

Transcription:

patient guide TumorNext-HR D a test for ovarian cancer patients to identify hereditary and tumor-specific mutations Because knowing can mean personalized treatment and management

Germline vs. Tumor Testing TumorNext-HRD looks for mutations in your tumor (also referred to as somatic testing) and inherited (germline) mutations in your blood. It is important to understand the key differences between germline and tumor genetic tests, each can provide very different information about your health and your family. what s the difference? WHAT IS TESTED? INHERITANCE RISKS inherited (germline) Blood or saliva Genes that are identical in all cells of your body Can be inherited and passed on to family members Linked to an increased risk for other cancer(s) tumor (somatic) Your tumor tissue for cancer-specific changes Not inherited and only present in your tumor cells. Cannot be passed to family members Does not increase your risk for other cancers Can impact your treatment By testing normal tissue (blood or saliva) and tumor tissue, we can detect both types of mutations to give you and your healthcare provider more information about how to best care for you and your family.

What is TumorNext-HRD? Some of the genes in our body help to fix errors in our DNA in a process called homologous recombination. When one of these genes has a mutation, this process may not work well, which can lead to the development of cancer. These mutations cause something called homologous recombination deficiency or HRD. Knowing if a person has a genetic mutation, like those that cause HRD, can tell us if she may be a candidate for targeted treatments, such as PARP inhibitors. tumornext-hrd For patients with ovarian cancer Looks for inherited genetic mutations and tumor mutations at the same time with one test germline (inherited ) tumor (somatic) Learning if you have an inherited mutation can help you understand the cause of your ovarian cancer, and future cancer risks for you and your family. Learning if you have a mutation in your tumor that causes HRD can help you understand if you may be eligible for targeted treatments, like PARP inhibitors. Results could also impact your recommended treatment and cancer screening options. what are parp inhibitors? PARP inhibitors can sometimes be used to treat ovarian cancer. This may be referred to as targeted treatment because it targets unique traits of a tumor to selectively kill cancer cells. Before PARP inhibitors are prescribed, germline and tumor genetic testing are often used to find the right patients for this drug to be effective.

Know the Basics: Inherited Mutations and Hereditary Cancer types of cancer sporadic cancer Happens by chance in one or two related family members, typically at older ages hereditary cancer A clustering of cancer in a family due to inherited gene changes (germline mutations), which can be passed from parent to child about hereditary cancer Many people have a family history of cancer, but only 10-25% of ovarian cancer is hereditary. People who have these gene mutations are born with them they do not develop over time. Learning if you have an inherited (germline) mutation can help you know more about your cancer risks. People with a higher chance of developing cancer may need screening, like mammograms, that start at younger ages, and occur more often.

Understanding Disease Better Through Quality Testing your genes carry a story that is unique to you and makes you who you are. genetic testing can help you better understand your risks for cancer. Genetic testing for hereditary ovarian cancer can include a varying number of genes, including BRCA1/2, that are linked to an increased lifetime risk for ovarian, breast and/or other cancers. Some of these genes may also be linked to HRD. Based on your results, your healthcare provider may discuss more specific cancer risks for you and your family. Hereditary Breast and Ovarian Cancer Lifetime Risks (%) 45-87 General population 11-40 Germline (inherited) mutations in BRCA1 or BRCA2 12 2 0.1 >6 5.8* 15* increased 1.5 2.5 increased** Breast Ovarian Male Breast Prostate Pancreatic Melanoma * Risk to 60-69 years old and up to 65 years old, respectively ** Risk for BRCA2 only Your healthcare provider has determined that the best test for you is: TumorNext-HRD TumorNext-BRCA OvaNext Other: visit our website For more information about TumorNext-HRD, visit our website. ambrygen.com

What are the Benefits of TumorNext-HRD? benefits of both germline and tumor testing: Your doctor can discuss the possibility of other personalized treatment options based on your genetic test results, including more targeted drug therapies such as PARP inhibitors. benefits of germline genetic testing: Your healthcare provider can adjust your cancer screening plan (such as age of initial screening, type, and frequency) based on your genetic test results. Examples of cancer screening are mammograms or breast MRI Your healthcare provider may discuss possible cancer prevention options, such as preventive surgery to reduce the risk for certain cancers. Examples are prophylactic mastectomy (removing one or both breasts before a cancer occurs)

for your family members: If you test positive for an inherited genetic mutation, your close family members (like your parents, brothers, sisters, children) have a 50/50 random chance of also having the same mutation. Has genetic mutation No mutation Men and women have the same chance to inherit a mutation, but their chance to develop cancer may be different. Typically genetic testing is recommended for adults, but it is important to discuss genetic testing for children under age 18 with your healthcare provider to determine if it may be helpful.

Possible Genetic Test Results a germline (inherited) mutation linked to an increased risk for cancer was found in one of the genes tested. Personalized treatment and management recommendations may be available to you based on your genetic test results. Genetic testing for certain family members may be recommended somatic (tumor) mutation was found in one of the genes tested. Targeted treatment options may be available to you. Cancer risk(s) and management recommendations are based on personal and family history no genetic changes were found in any of the genes tested Cancer risk(s) and management recommendations are based on personal and family history? variant of unknown significance (vus) At least one genetic change was found, but it is unclear if this change causes an increased risk for cancer or not Cancer risk(s) and treatment recommendations are based on personal and family history For negative or VUS results, talk to your healthcare provider to determine if relatives would benefit from any additional genetic testing. It is possible to have a combination of positive and VUS results, since multiple genes are tested.

Resources For You organizations you may want to connect with: Ambry s Hereditary Cancer Site For Families patients.ambrygen.com/cancer Genetic Information Nondiscrimination Act ginahelp.org American Cancer Society cancer.org National Cancer Institute cancer.gov American Society of Clinical Oncology cancer.net National Ovarian Cancer Coalition ovarian.org Foundation for Women s Cancer foundationforwomenscancer.org find a genetic counselor National Society of Genetic Counselors nsgc.org Canadian Association of Genetic Counsellors cagc-accg.ca

Frequently Asked Questions 1 how is genetic testing performed and how long does it take? Germline testing is done using a blood or saliva sample, which is collected using a special kit that is shipped overnight to Ambry (all coordinated by your healthcare provider). A sample of your ovarian tumor will also be needed for the tumor testing, and Ambry will request that this be sent by the Pathology department at your hospital. Testing looks for mutations that cause an increased risk for cancer. The time to complete the testing may depend on how quickly Ambry receives your tumor sample. After we receive the required samples, it will take 21-28 days for the results to be sent to your healthcare provider. 2 what will happen when my results are ready? Your healthcare provider will receive your results; they will not be sent directly to you. Every healthcare provider may have a different method and time frame to contact you to discuss your results, so it is important to discuss this process with them. Based on your test results, your healthcare provider will discuss any next steps. 3 will my genetic test results affect my insurance coverage? In the U.S., the Genetic Information Nondiscrimination Act (2008) prohibits discrimination by health insurance companies and employers, based on genetic information. Depending on where you live in the world, you may have different (or fewer) laws in this area. Visit ginahelp.org to learn more.

4 should i tell my family members about my genetic test results? It is important to share your germline (inherited) results with your family members since they may provide additional information about their cancer risks and management options. Everyone reacts differently to health-related news, but it s important to share your results with your family members. Since genetic test results can be shared in a number of ways, your healthcare provider may be able to guide you on finding the best way to inform family members. 5 will genetic testing be covered by my insurance? Many insurance plans cover germline genetic testing and Ambry is contracted with the majority of U.S. health plans. Your out-of-pocket cost may vary based on your individual plan; therefore, we offer personalized verification of insurance coverage and financial options for your genetic testing. With Ambry s E.P.I.C. (Every Patient Individually Considered) Program, your individual circumstances are considered for financial assistance. A team of dedicated specialists is available to help you get access to the genetic testing you need and answer any questions you have about our payment options. Call or email our Billing department at +1.949.900.5795 or billing@ambrygen.com with any questions. 6 what is an explanation of benefits (eob)? Your insurance company sends you an EOB to explain any services paid on your behalf. You can contact us directly to speak with a Billing specialist with any questions or concerns about your EOB. Some genetic tests take weeks to process in order to receive the best results. In addition, insurance companies can take several weeks or even a couple of months to process claims. still have questions? Talk to your doctor or visit our website: ambrygen.com

Finding Answers. 2017 Ambry Genetics Corporation 15 Argonaut, Aliso Viejo, CA 92656 USA Toll Free +1.866.262.7943 Fax +1.949.900.5501 TNHRDPG 50339.4866_v1 07.26.17